With the regulatory approval, company can now export its blood pressure monitor devices to the US, Europe, and other overseas countries along with tapping the burgeoning Indian market
Cognota Healthcare has announced that the United States Food and Drug Administration (USFDA) has approved the company’s blood pressure monitor device- ‘COGNOHEALTH Blood Pressure Monitor’, marking the foray of the company into the medical devices segment.
With the regulatory approval, company can now export its blood pressure monitor devices to the US, Europe, and other overseas countries along with tapping the burgeoning Indian market.
The ‘COGNOHEALTH Blood Pressure Monitor’ device is powered by technology that has been designed and developed by experts in Cognota’s R&D team. Approval from the USFDA enables Cognota to expand its existing portfolio of healthtech solutions that include Remote Patient Monitoring (RPM), teleconsultation platform, and smart ICU among others.